Immuneering (IMRX) Assets: 2020-2023
Historic Assets for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $102.6 million.
- Immuneering's Assets fell 39.80% to $68.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $68.6 million, marking a year-over-year decrease of 39.80%. This contributed to the annual value of $102.6 million for FY2023, which is 16.17% down from last year.
- According to the latest figures from FY2023, Immuneering's Assets is $102.6 million, which was down 16.17% from $122.4 million recorded in FY2022.
- Immuneering's 5-year Assets high stood at $166.7 million for FY2021, and its period low was $38.4 million during FY2020.
- Its 3-year average for Assets is $130.6 million, with a median of $122.4 million in 2022.
- Per our database at Business Quant, Immuneering's Assets spiked by 333.87% in 2021 and then declined by 26.60% in 2022.
- Immuneering's Assets (Yearly) stood at $38.4 million in 2020, then surged by 333.87% to $166.7 million in 2021, then declined by 26.60% to $122.4 million in 2022, then fell by 16.17% to $102.6 million in 2023.